Title

The role of multiparametric MRI in biopsy-naive prostate cancer

Document Type

Journal Article

Publication Date

5-1-2019

Journal

Nature Reviews Urology

Volume

16

Issue

5

DOI

10.1038/s41585-019-0173-7

Abstract

© 2019, US Government. Results of recent trials have shown the superiority of mpMRI to TRUS-guided systematic biopsy for detecting clinically significant prostate cancer. However, only performing an mpMRI risks missing MRI-invisible lesions and, therefore, there might be added value in performing both targeted and systematic biopsies in biopsy-naive patients.

This document is currently not available here.

Share

COinS